[S12] New directions of T cell receptor research ~ beyond classical views ~

9:00 〜 9:30

[S12-01] Identification of Immunogenic Neoantigens from ARID1A-Deficient Tumors During the Development of Resistance to Targeted Therapy

^○Shin-ichiro Fujii^1,2,3 (1.RIKEN IMS, Lab for Immunotherapy, 2.RIKEN IMS, aAVC Drug Tranlational Unit, 3.RIKEN Drug discovery and medical technology platforms (DMP))

キーワード：

tumor、neoantigen、therapy

閲覧にはパスワードが必要です

ログイン

または